SKI Market

A+| A| A-|

Indian Indices

Sensex

71,947.55 -1,635.67
( -2.22%)

Global Indices

Nasdaq

45,242.12 54.47
(0.12%)

Dow Jones

6,365.58 -24.27
(-0.38%)

Hang Seng

51,264.29 -621.56
(-1.20%)

Nikkei 225

10,127.96 160.61
(1.61%)

Forex

USD-INR

94.53 0.44
(0.47%)

EUR-INR

108.77 0.13
(0.12%)

GBP-INR

125.32 -0.25
(-0.20%)

JPY-INR

0.59 0.00
(-0.02%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Beta Drugs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

535022

INE351Y01019

139.8706763

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BETA

95.53

1205.58

EPS(TTM)

Face Value()

Div & Yield %

12.45

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	220.20	197.62	157.87	124.85	79.46	65.32
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	220.20	197.62	157.87	124.85	79.46	65.32
Other Income	6.19	1.73	1.04	0.86	0.61	0.42
Stock Adjustments	3.70	6.97	3.17	-0.86	1.38	-0.20
Total Income	230.09	206.32	162.08	124.85	81.45	65.54
EXPENDITURE :
Raw Materials	123.50	119.27	86.47	69.86	44.83	34.61
Power & Fuel Cost	4.22	3.83	3.06	2.28	1.84	1.46
Employee Cost	15.00	11.08	10.31	6.70	4.53	3.70
Other Manufacturing Expenses	18.02	13.61	12.51	10.04	7.65	6.64
Selling & Administrative Expenses	31.10	22.77	17.08	9.61	6.23	6.59
Miscellaneous Expenses	5.22	0.50	0.42	0.31	0.45	0.37
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	197.05	171.07	129.85	98.80	65.53	53.36
Operating Profit	33.04	35.26	32.24	26.04	15.92	12.17
Interest	4.76	1.05	0.84	0.41	0.77	0.64
Gross Profit	28.28	34.21	31.40	25.63	15.15	11.53
Depreciation	7.44	4.72	6.19	5.47	5.27	2.58
Profit Before Tax	20.84	29.49	25.21	20.16	9.88	8.95
Tax	5.70	7.47	6.68	6.15	3.30	1.72
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.29	0.08	-0.29	-0.24	-0.40	0.13
Reported Net Profit	15.43	21.94	18.82	14.25	6.98	7.10
Extraordinary Items	-3.32	0.00	0.00	0.00	0.00	0.00
Adjusted Net Profit	18.75	21.94	18.82	14.25	6.98	7.10
Adjustment below Net Profit	-2.42	-2.18	-0.02	-0.20	0.00	0.00
P & L Balance brought forward	82.46	62.70	43.91	29.86	22.89	15.79
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	95.47	82.46	62.70	43.91	29.86	22.89
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	15.29	22.82	19.57	14.82	7.26	7.39
Earnings Per Share(Adj)-Unit Curr	15.29	22.82	18.64	14.82	6.91	7.04
Book Value-Unit Curr	127.83	120.67	100.12	80.57	65.96	58.71
Book Value(Adj)-Unit Curr	127.83	120.67	95.35	80.57	62.82	55.92

71,947.55 -1,635.67 ( -2.22%)

45,242.12 54.47 (0.12%)

6,365.58 -24.27 (-0.38%)

51,264.29 -621.56 (-1.20%)

10,127.96 160.61 (1.61%)

94.53 0.44 (0.47%)

108.77 0.13 (0.12%)

125.32 -0.25 (-0.20%)

0.59 0.00 (-0.02%)